USPTO Can't Be Blamed For Patent On 'Fraud' Stem Cells

Law360, New York (February 19, 2014, 8:49 PM EST) -- The U.S. Patent and Trademark Office's decision to issue a human stem cell patent to a scientist found years ago to have fabricated his work may seem like sloppy work by the agency, but attorneys say the office doesn't have the ability to test the bona fides of an invention, nor does it need to in a system that renders fraudulent patents unenforceable.

Korean researcher Hwang Woo-suk, who was convicted of embezzling research funds after his claim to have created the world's first cloned human embryos...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.